We spoke to three people about their experience of breast surgery and some of the difficult decisions they made along the way.
Prostate cancer screening is back in the news, as results from a targeted screening programme are released. But when it comes to yearly checks, are we there yet?
The immunotherapy drug nivolumab (Opdivo) has been made available for some people in England with oesophageal cancer, in what has been described as a ‘step change’ for people with this cancer.
We speak to Professor Shankar Balasubramanian about his work on NGS, his incredible translational journey and the power of the pub…
We hear from Rosie Lomas – the ‘Excellence in Cancer Research Nursing Award’ winner – and the other shortlisted nurses about their work and the vital role they play in delivering clinical trials.
The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.
Elaine Whelan has pledged 10% of her estate to help fuel the research of tomorrow. Here, she tells us why she chose to support our work with a significant gift in her Will.
In 2004, we joined forces with TK Maxx to raise awareness and funds for children’s and young people’s cancers. Since…
We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early.